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EDITORIAL
Glucose toxicity
Glycation of proteins and lipids occurs as a conse- cells also respond to glycated albumin using transforming
quence of a nonenzymatic reaction between these enti- growth factor-b1 (TGF-b1) and PKC pathways.
ties and glucose. These products are progressively modi- Other investigators have focused on the effects of dif-
fied, nonenzymatically, to eventually form a stable group ferent reactive intermediates in the cascade of chemical
of molecules referred to as advanced glycation end prod- moieties formed as a result of glucose-protein interac-
ucts (AGEs). These glucose products, also referred to tions, including studies of numerous other tissues. In
as glycotoxins, accumulate from aging and the amounts most studies, the authors focused on the addition of
are greatly increased in diabetics as a result of continuous glucose adducts to cells in vitro. Some examined animal
hyperglycemia [1]. These adducts have deleterious ef- tissues after the systemic administration of mixtures of
fects on both large and small blood vessels [2]. Most glucose adducts. The use of inhibitors of adduct forma-
cells have surface receptors, including mesangial cells, tion, or breakers of formed adducts, attest to their pres-
that recognize these adducts. Grouped under the generic ence in tissues and their induction of lesions therein [8].
title of AGE receptors, these receptors mediate both One issue that should be studied further is that only
the uptake of AGEs and mediate cellular responses to a fraction of diabetics develop end-organ damage. In the
AGEs. The responses are multiple, including the release case of the kidney, this amounts to approximately 30%
of growth factors and cytokines, changes in extracellular of those at risk. This fact, and the observation that several
matrix turnover, and alterations in growth control [2]. genes appear to be associated with an increased risk
Many of these responses are considered to be important for diabetic nephropathy, supports the hypothesis that
in the genesis of diabetic nephropathy. Protein kinase C genetic susceptibility plays a major role in the develop-
(PKC) has been shown to be very important in the gene- ment of this complication.
sis of glucose-related responses in both mesangial cells Even with the best control of glycemia in either type
and whole glomeruli [3–5]. The importance of the b 1 or type 2 diabetes, the development of nephropathy
isoform of PKC was recently emphasized in studies is not eradicated, even though glycemic control is critical
showing that inhibition of this isoform ameliorated both to reduce the risk for nephropathy [9].
retinal and renal lesions in diabetic rats [5]. There is a vast difference between individuals and
AGEs are removed by proteolysis at tissue sites, either their response to glucose adducts. This has been well
nonspecific or receptor-directed release. Since renal ex- documented in experimental animals. For instance, we
cretion is the principal means by which AGEs are elimi- found that certain mouse strains develop severe glomer-
nated from the body, decreased renal function would be ulosclerosis after the onset of diabetes, whereas others
expected to compound the injury because these products did not [10]. Furthermore, the susceptibility of devel-
accumulate in tissues and body fluids. oping glomerulosclerosis was independent of the type
The senior authors of one study in this issue of Kidney of eliciting stimulus. Specifically, nephron reduction in
International have provided a series of observations link- adulthood and toxin exposure in utero or in vitro all
ing early members of the reaction between glucose and elicited an abnormal response resulting in glomeruloscle-
proteins, Amadori-glucose adducts, to glomerular mes- rosis [11]. Others have observed similar effects in dia-
angial cell responses that favor the development of the betic rats, that is, diabetic BB rats do not develop glomer-
accumulation of extracellular matrix [6]. They have also ulosclerosis, diabetic Sprague-Dawley rats develop focal
shown that administering antibodies to these early glu- lesions, and diabetic fawn-hooded rats develop diffuse
cose adducts inhibits the development of nephropathy glomerulosclerosis. Finally, it may be necessary to exam-
in db/db mice (a model of spontaneous diabetes mellitus) ine cells from animals and patients who either have, or
[7]. Their current study now expands their observations have been shown to develop, diabetic nephropathy, since
to include mouse glomerular endothelial cells in vitro, we have shown that mesangial cells under these condi-
and demonstrates that mouse glomerular endothelial tions have a stable phenotypic change that results in
unique responses to agonists [12].
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